Email this article 
Post a Comment Prognostic value of assessment of glial cell line-derived neurotrophic factor in ischemic stroke patients
- Authors: Kurakina A.S.1, Semenova T.N.2, Schelchkova N.A.2, Guzanova E.V.2,3, Mukhina I.V.2, Karakulova J.V.1, Grigorieva V.N.2
-
Affiliations:
- E.A. Vagner Perm State Medical University
- Privolzhsky Research Medical University
- Nizhny Novgorod Regional Clinical Hospital named after N.A. Semashko
- Issue: Vol 38, No 2 (2021)
- Pages: 95-102
- Section: Preventive and social medicine
- URL: https://journals.rcsi.science/PMJ/article/view/60607
- DOI: https://doi.org/10.17816/pmj38295-102
- ID: 60607
Cite item
Full Text
Abstract
Objective. The aim of the study was to estimate the prognostic value of GDNF in acute IS patients. Glial neurotrophic factor (GDNF) is a neuropeptide, which promotes the proliferation and differentiation of the cells of the central and peripheral nervous system, possesses antihypoxic and neuroprotective properties in ischemic stroke (IS).
Materials and methods. 50 patients with first-ever acute IS were examined at the National Institutes of Health Stroke Scale (NIHSS); modified Rankin scale was used on admission to the hospital, 7 and 14 days after stroke. The plasma GDNF level was measured at the first 48 hours and after 7 days of IS onset. GDNF was analyzed by commercially available ELISA kit. The comparison group included 20 healthy persons.
Results. The average GDNF level in the group of patients with IS (3.4 [2.8; 5.0] pg/ml) was significantly higher than in the group of healthy individuals (2.8 [2.6; 2.9] pg/ml), p = 0.02.
The risk of unfavourable functional outcome on the day 14 after IS onset was higher by 2.8-fold in those patients whose level of GDNF was increased on the 7th day of the disease by more than 30% compared to its level in the first 48 hours (RR = 2,8; 95% CI [1,4–5,7]).
The GDNF level less than 2.9 pg/ml was associated with a high risk of death during 14 days after the IS onset (RR = 6,7; 95% CI [1,5–30,5]).
Conclusions. Plasma concentrations of GDNF have a high predictive value for unfavorable functional outcome and risk of death in acute period of IS.
Full Text
##article.viewOnOriginalSite##About the authors
Anastasia S. Kurakina
E.A. Vagner Perm State Medical University
Author for correspondence.
Email: nansy.trifonova@mail.ru
ORCID iD: 0000-0001-6058-9476
ResearcherId: ABH-3974-2020
candidate of medical Sciences, assistant lecturer of the depaetment of neurology and medical genetics
Russian Federation, PermTatyana N. Semenova
Privolzhsky Research Medical University
Email: neurotmdoc@gmail.com
Assistant, Department of Diseases of Nervous System
Russian Federation, Nizhny NovgorodNatalia A. Schelchkova
Privolzhsky Research Medical University
Email: natalia-shelchkova@rambler.ru
Candidate of Biological Sciences, Head of Central Scientific Research Laboratory, Associate Professor of Department of Normal Physiology named after N.Yu. Belenkov
Russian Federation, Nizhny NovgorodElena V. Guzanova
Privolzhsky Research Medical University; Nizhny Novgorod Regional Clinical Hospital named after N.A. Semashko
Email: el.guzanova@yandex.ru
Candidate of Medical Sciences, Assistant, Department of Diseases of Nervous System, neurologist of Unit for Stroke Patients
Russian Federation, Nizhny NovgorodIrina V. Mukhina
Privolzhsky Research Medical University
Email: mukhinaiv@mail.ru
Doctor of Biological Sciences, Professor, Director of Institute of Fundamental Medicine, Head of Department of Normal Physiology named after N.Yu. Belenkov
Russian Federation, Nizhny NovgorodJulia V. Karakulova
E.A. Vagner Perm State Medical University
Email: julia.karakulova@mail.ru
MD, PhD, Professor, Head of Department of Neurology and Medical Genetics
Russian Federation, PermVera N. Grigorieva
Privolzhsky Research Medical University
Email: vrgr@yandex.ru
MD, PhD, Professor, Head of Department of Diseases of Nervous System
Russian Federation, Nizhny NovgorodReferences
- Shishkina T.V., Vedunova M.V., Mishchenko T.A., Mukhina I.V. The Role of Glial Cell Line-Derived Neurotrophic Factor in the Functioning of the Nervous System (Review). Sovremennye tekhnologii v meditsine 2015; 7 (4): 211–215 (in Russian).
- Airaksinen M.S., Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 2002; 3(5): 383–394.
- Mitroshina E.V., Abogessimengane B.Zh., Urazov M.D., Khamrauy I., Mishchenko T.A., Astrakhanova T.A., Shchelchkova N.A., Lapshin R.D., Shishkina T.V., Belousova I.I., Mukhina I.V., Vedunova M.V. Adaptive Role of Glial Cell Line-Derived Neurotrophic Factor in Cerebral Ischemia. Sovremennye tekhnologii v meditsine 2017; 9 (1): 68–77 (in Russian).
- Fantacci C., Capozzi D., Ferrara P., Chiaretti A. Neuroprotective Role of Nerve Growth Factor in Hypoxic-Ischemic Brain Injury. Brain Sciences 2013; 3(3): 1013–1022.
- Vedunova M.V., Sakharnova T.A., Mitroshina E.V., Shishkina T.V., Astrakhanova T.A., Mukhina I.V. Antihypoxic and Neuroprotective Properties of BDNF and GDNF in vitro and in vivo Under Hypoxic Conditions. Sovremennye tekhnologii v meditsine 2014; 6(4): 38–47 (in Russian).
- Zhang Y., Jiang H., Yue Y., Yin Y., Zhang Y., Liang Y., Li S., Wang J., Lu J., Geng D., Wu A., Yuan Y. The protein and mRNA expression levels of glial cell line-derived neurotrophic factor in post stroke depression and major depressive disorder. Sci Rep 2017; 7(1), available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561249/.
- Stanne T.M., Åberg N.D., Nilsson S., Jood K., Blomstrand K., Andreasson Ulf, Blennow K., Zetterberg H., Isgaard J., Svensson J., Jern C. Low circulating acute brain-derived neurotrophic factor levels are associated with poor long-term functional outcome after ischemic stroke. Stroke 2016; 47(7): 1943–1945.
- Azevedo MD, Sander S., Tenenbaum L. GDNF, A Neuron-Derived Factor Upregulated in Glial Cells during Disease. J Clin Med 2020; 9(2): 456–469.
- Smirkin A., Matsumoto H., Takahashi H., Inoue A., Tagawa M., Ohue S., Watanabe H., Yano H., Kumon J., Ohnishi T., Tanaka J. Iba1+/NG2+ macrophage-like cells expressing a variety of neuroprotective factors ameliorate ischemic damage of the brain. J Cereb Blood Flow Metab 2010; 30: 603–615.
- Tokumine J., Kakinohana O., Cizkova D., Smith D.W., Marsala M. Changes in spinal GDNF, BDNF, and NT-3 expression after transient spinal cord ischemia in the rat. J Neurosci Res 2003; 74: 552–561.
- Capani F., Quarracino C., Caccuri R., Sica R.E. Astrocytes as the main players in primary degenerative disorders of the human central nervous system. Front Aging Neurosci 2016; 8, available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777729/.
- Ibáñez C.F. Structure and physiology of the RET receptor tyrosine kinase. Cold Spring Harbor Perspectives in Biology 2013; 5(2), available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552510/.
- Lasek-Bal A., Jędrzejowska-Szypułka H., Różycka J., Bal W., Holecki M., Duława J., Lewin-Kowalik J. Low concentration of BDNF in the acute phase of ischemic stroke as a factor in poor prognosis in terms of functional status of patients. Medical science monitor: international medical journal of experimental and clinical research 2015; 21: 3900 – 3905.
- Shchelchkova N.A., Kokaya A.A., Bezhenar' V.F., Rozhdestvenskaya O.V., Mamedova M.A., Mishchenko T.A., Mitroshina E.V., Vedunova M.V. The Role of Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in Chronic Fetal Oxygen Deprivation. STM 2020; 12(1): 25–33 (in Russian).
Supplementary files
